Immix Biopharma share price logo

Immix Biopharma

NASDAQ: IMMX

Small Cap

$7.62

-0.37

(-4.57%)

Live

as on

Immix Biopharma Stock Performance

as on October 31, 2026 at 3:29 am IST

  • Day's Low

    Day's High

    $7.61
    $8.10
    downward going graph

    0.13%

    Downside

    6.30%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.85
    $15.10
    downward going graph

    62.58%

    Downside

    98.16%

    Upside

    downward going graph

Immix Biopharma share price movements today

Previous Close
$7.98
Open
$7.92
Volume
400.9K
Market Cap
$673.6M
Day's Low - High
$7.61 - $8.10
52 Week Low - High
$2.85 - $15.10

Immix Biopharma Historical Returns

1 Month Return
-23.31 %
3 Month Return
-6.67 %
1 Year Return
+ 117.44 %
3 Year Return
+ 141.09 %
5 Year Return
0 %

Immix Biopharma Stock Fundamentals & Key Indicators

Check Immix Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$673.6M

EPS (TTM)

-0.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.23

Industry PE ratio

-7.60

PEG Ratio

0.69

EBITDA

-40.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-38.44%

Immix Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immix Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$673.6MNA-9.230.00%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Immix Biopharma Stock including INR - Dollar returns

The Immix Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immix Biopharma investment value today

Current value as on today

₹2,22,430

Returns

₹1,22,430

(+122.43%)

Returns from Immix Biopharma Stock

₹1,07,629 (+107.63%)

Dollar Impact

₹14,801 (+14.8%)

Analyst Recommendation on Immix Biopharma Stock

Based on 4 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for Immix Biopharma. Average target price of $24.43

Immix Biopharma Share Price Target

Get share price movements and forecasts by analysts on Immix Biopharma.

What analysts predicted

68.81%UPSIDE

Target Price

$24.43

Current Price

$7.62

Analyzed by

4 Analysts

High

$30

Target

$24.43

Low

$23

Immix Biopharma target price $24.43, a slight upside of 68.81% compared to current price of $7.62. According to 4 analysts rating.

Indian Investors' Interest in Immix Biopharma Stock

Search interest for Immix Biopharma Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Immix Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-5
-4
-7
-4
-4
-6
-7
-10
-10
-12
EBITDA
-5
-4
-7
-4
-4
-6
-7
-10
-10
-11
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-4
-7
-4
-4
-6
-7
-10
-10
-11
Income Tax Expense
0
0
0
0
0
0
0
0
-
0
Net Income
-5
-4
-7
-4
-4
-6
-7
-10
-10
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immix Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
Operating Income
0
0
-1
-8
-16
-22
-29
EBITDA
0
0
-24
-8
-15
-21
-29
Interest Expense
0
0
0
0
-
-
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
0
-1
-24
-8
-15
-21
-29
Income Tax Expense
0
0
0
0
0
0
0
Net Income
0
-1
-24
-8
-15
-21
-29
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Immix Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-4
-7
-4
-4
-6
-7
-10
-10
-11
Operating Cash Flow
-3
-5
-4
-1
-1
-5
-5
-11
-9
-11
Investing Cash Flow
0
0
0
0
0
0
0
-6
-4
2
Financing Cash Flow
15
-
-
-
-
1
10
95
0
155
Change in Cash
11
-5
-4
-2
-1
-4
4
77
-14
146

Immix Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
-1
-24
-8
-15
-21
-29
Operating Cash Flow
0
0
-1
-7
-11
-14
-23
Investing Cash Flow
0
-
0
-
0
-1
-7
Financing Cash Flow
1
-
18
3
15
15
107
Change in Cash
0
0
17
-4
4
0
76

Global Institutional Holdings in Immix Biopharma

Check out the Institutions with significant holdings in Immix Biopharma.

Funds
Holdings
MUTUAL FUND SERIES TRUST
4.69%
Vanguard
4.27%
VANGUARD INDEX FUNDS
2.97%
SPDR
2.85%
iShares
2.81%

Immix Biopharma News & Key Events

  • img

    Today's Timeline - 29 September

    Tue, 05:01 PM

    -

    Immix Biopharma reports interim Phase 2 results showing NXC-201 achieved an 89% complete response rate in AL amyloidosis patients.

    Tue, 05:03 PM

    -

    Immix Biopharma prices $125M stock offering of 11.36M shares at $11 per share, expected to close by September 30.

Insights on Immix Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, IMMX stock has moved up by 117.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 200.7% return, outperforming this stock by 59.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 574.2%

About Immix Biopharma

Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas are oncology (cancer) and inflammatory diseases. Their product pipeline includes IMX-110, which is currently undergoing Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and various solid tumors. They are also developing IMX-111, a targeted biologic agent for colorectal cancers, and IMX-120, another tissue-specific biologic designed to address ulcerative colitis and severe Crohn's disease. In a strategic move, the company has forged a clinical collaboration and supply agreement with BeiGene Ltd. This partnership aims to conduct a Phase 1b combination clinical trial, evaluating IMX-110 in conjunction with BeiGene's anti-PD-1 drug, Tislelizumab, for solid tumor indications. Founded in 2012, Immix Biopharma maintains its headquarters in Los Angeles, California.
OrganisationImmix Biopharma
Headquarters11400 West Olympic Boulevard, Los Angeles, CA, 90064, US
IndustryBiotechnology
CEOIlya Rachman

Key Management of Immix Biopharma

Name

Title

Dr. Graham Ross FFPM, M.D.

Chief Medical Officer & Head of Clinical Development

Dr. David Marks MBBS, Ph.D.

Chief Medical Officer of Cell Therapy

Mr. Mel Davis-Pickett

Head of CMC Technical Development

Mr. Michael A. Grabow

Chief Commercial Officer

Dr. Ilya Rachman M.B.A., M.D., Ph.D.

Co-Founder, CEO, Chief Scientific Officer & Chairman

Mr. Gabriel Morris B.A.

President, CFO & Director

Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.

Scientific Co-Founder

FAQs

What is Immix Biopharma share price today?

Immix Biopharma share price today is $7.62 as on . Immix Biopharma share today touched a day high of $8.10 and a low of $7.61.

What is the 52 week high and 52 week low for Immix Biopharma share?

Immix Biopharma share touched a 52 week high of $15.10 on and a 52 week low of $2.85 on . Immix Biopharma stock price today i.e. is trending at $7.62,which is 49.54% down from its 52 week high and 167.25% up from its 52 week low.

What is Immix Biopharma's market capitalisation today?

Immix Biopharma market capitalisation is $0.00T as on .

How to invest in Immix Biopharma Stock (IMMX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immix Biopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Immix Biopharma Stock (IMMX) from India?

Indian investors can start investing in Immix Biopharma (IMMX) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Immix Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Immix Biopharma share’s latest price of $7.62 as on October 30, 2026 at 9:59 pm IST, you will get 1.3123 shares of Immix Biopharma. Learn more about fractional shares .